Transaction

Clearwater advises i2i on its sale to IG&H

Transaction

i2i sold to IG&H backed by IK Partners

Sell-side

Undisclosed

Role

Adviser to i2i on its sale to IG&H

Sector

Tech & Tech Services
Healthcare

Region

Netherlands

Clearwater has advised i2i, a specialist data-analysis organisation in the field of healthcare effectiveness, on its sale to IG&H, a leading Netherlands based consulting and technology company. With this acquisition, IG&H strengthens its services in the healthcare industry.

i2i is a unique player in the Dutch healthcare market, specialising in healthcare effectiveness analysis. Across 10 years, the company has delivered significant social value to the Dutch healthcare system and is a Trusted Third-Party (TTP) for health insurers and institutions. i2i uses data to analyse effectiveness and quality of care in hospitals and elderly care institutions, identifying areas for improvement, which lead to the implementation of effective changes.

Active in the healthcare sector since 2005, IG&H is a leading consulting and technology company specialising in retail, financial services, and healthcare. The business is able to realise complex transformations that keep healthcare patient-centered, affordable, and accessible. IG&H combines sector knowledge with digital transformation and technology competencies, offering fast, flexible, and cost-effective solutions through low-code platforms. With over 400 professionals in Europe, the company is officially recognised as a Great Place to Work.

i2i will become an independent subsidiary of IG&H, retaining its own position and direct relationship as a contracting party for health insurers and healthcare providers. The company will also continue to fully function as a TTP.

Healthcare data

This acquisition will allow i2i to further develop its services and increase its impact. IG&H and i2i share the same vision for healthcare in the Netherlands, which is to keep it affordable and accessible. We are very pleased to have worked with Joris Heerkens and the Clearwater team on this important transaction.

Birgitta de Gruijter, CEO, i2i
Healthcare data

i2i is a valuable addition to the company's portfolio and will help IG&H to further increase its impact on the healthcare sector.

Bas Leerink, Managing Director, IG&H Health

Advisers

Transactions